SEC Form 4 · accession 0000059478-18-000140
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christi Shaw
Officer — SVP and Pres., Lilly Bio-Meds
Period of report
May 1, 2018
Accepted (ET)
May 3, 2018 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2018 | M | 13,750 | $0.00 | A | 13,750 | D | |
| Common Stock | May 1, 2018 | F | 5,324 | $81.07 | D | 8,426 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | May 1, 2018 | M | 13,750 | D | — | — | Common Stock | 13,750 | 13,750 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
- F2The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019.